Expanded Access Intermediate Size Treatment Protocol: Pritelivir for Immunocompromised Subjects With Treatment Resistant Herpes Simplex Virus Type 1 or 2
Condition: HSV Intervention: Drug: Pritelivir Sponsors: AiCuris Anti-infective Cures AG; Impatients N.V. trading as myTomorrows Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 6, 2023 Category: Research Source Type: clinical trials
